ADC Therapeutics vs Verastem
ADCT and VSTM side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ADCT and VSTM compare
Verastem is the larger company, worth 4.3 times as much as ADC Therapeutics ($741M against $171M).
ADC Therapeutics keeps more of each dollar of sales as profit, with a net margin of −95.7% compared with −178% at Verastem.
ADC Therapeutics scores higher on the StockData Score (4 against 3 for Verastem), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ADCT | VSTM |
|---|---|---|
| Size and price | ||
| Market cap | $171M | $741M |
| Share price | $1.34 | $8.18 |
| Change, 1 year | −66.9% | −3.9% |
| Change, 5 years | −94.1% | −77.0% |
| Beta (5Y) | 1.96 | 1.37 |
| Employees | 188 | 102 |
| StockData Score | ||
| Total score | 4 (better) | 3 |
| Valuation score | 1 (better) | 0 |
| Growth score | 1 | 1 |
| Performance score | 1 | 1 |
| Health score | 1 | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 2.0× (better) | 7.4× |
| P/B | – | 73.3× |
| FCF yield | −58.8% | – |
| Growth | ||
| Revenue growth (TTM) | 12.8% | – |
| Revenue growth, 5Y average | – | −19.0% |
| Profitability | ||
| Operating margin | −97.7% (better) | −194% |
| Net margin | −95.7% (better) | −178% |
| FCF margin | −118% | – |
| Financial health | ||
| Interest coverage | −1.6× (better) | −141.9× |
| Current ratio | 3.05 (better) | 1.93 |
| Altman Z-score | −9.14 | −7.82 (better) |
| Piotroski F-score | 6 (better) | 4 |
| Dividends and buybacks | ||
| Buyback yield | −25.0% | – |
| Shareholder yield | −25.0% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 72.9% | 109% |
| Held by insiders | 42.8% | 1.8% |
| Insider net buying, 12 months | −$19.6M | −$816K (better) |
| Short interest, % of float | 8.8% | 22.1% |
Go deeper
- ADCT stock overview
- ADCT income statement
- ADCT valuation and score
- VSTM stock overview
- VSTM income statement
- VSTM valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.